| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABSTRACT CONTRIBUTOR STATEMENTS OF FINANCIAL SUPPORT
|
|
|
1999
|
2 |
1 |
p. 59-62
4 p.
|
artikel
|
| 2 |
CAN2: A NEW METHOD FOR EXPRESSING SURVIVAL AND LIFE EXPECTANCY IN CANCER PATIENTS
|
Messori, A
|
|
1999
|
2 |
1 |
p. 6-7
2 p.
|
artikel
|
| 3 |
CAN1: COST-EFFECTIVENESS ANALYSIS OF HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE AS PRIMARY TREATMENT FOR METASTATIC BREAST CANCER
|
Trippoli, S
|
|
1999
|
2 |
1 |
p. 6-
1 p.
|
artikel
|
| 4 |
CAN3: PRACTICE PATTERNS OF CHEMOTHERAPY USAGE AND ASSOCIATED NEUTROPENIA AND FEBRILE NEUTROPENIA (FN) IN EUROPE
|
Lyman, GH
|
|
1999
|
2 |
1 |
p. 7-
1 p.
|
artikel
|
| 5 |
CV2: COST-EFFECTIVENESS OF TREATING HIGH-RISK INDIVIDUALS, AGED 45-65, WITH STATINS IN GERMANY FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART DISEASE
|
Lauterbach, KW
|
|
1999
|
2 |
1 |
p. 12-13
2 p.
|
artikel
|
| 6 |
CV5: ECONOMIC ASSESSMENT OF A PROPHYLACTIC TREATMENT OF RECURRENCE OF ISCHEMIC ACCIDENTS BY LYSINE ACETYLSALICYLATE
|
Marissal, JP
|
|
1999
|
2 |
1 |
p. 14-
1 p.
|
artikel
|
| 7 |
CV4: IMPROVED MYOCARDIAL PROTECTION DURING CORONARY BYPASS SURGERY SHORTENS HOSPITAL STAY AND SAVES COSTS
|
Mehlhorn, U
|
|
1999
|
2 |
1 |
p. 13-
1 p.
|
artikel
|
| 8 |
CV6: OUTCOME OF ACUTE MYOCARDIAL INFARCTION PATIENTS WITH MAXIMAL INDIVIDUAL THERAPY (MITRA-STUDY)
|
Dommke, C
|
|
1999
|
2 |
1 |
p. 14-
1 p.
|
artikel
|
| 9 |
CV1: PRELIMINARY QUALITY-OF-LIFE EVALUATION OF THE GERMAN SAT TRIAL: COMPARISON OF SF-36, EUROQOL, TIME TRADE-OFF METHOD, AND WILLINGNESS TO PAY METHOD
|
Kurscheid, T
|
|
1999
|
2 |
1 |
p. 12-
1 p.
|
artikel
|
| 10 |
CV3: UTILIZATION OF ACE INHIBITORS IN CONGESTIVE HEART FAILURE AMONG THE ELDERLY IN QUEBEC
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 13-
1 p.
|
artikel
|
| 11 |
D3: ANTITHYROID DRUGS OR RADIOIODINE AS FIRST-LINE THERAPY OF GRAVES' HYPERTHYROIDISM IN A COUNTRY WITH STRICT REGULATIONS FOR RADIATION PROTECTION?
|
Dietlein, M
|
|
1999
|
2 |
1 |
p. 18-
1 p.
|
artikel
|
| 12 |
D4: MEASURING THE IMPACT OF DIABETIC FOOT ULCERS ON QUALITY OF LIFE FROM THE PATIENT'S PERSPECTIVE
|
Ward, J
|
|
1999
|
2 |
1 |
p. 18-
1 p.
|
artikel
|
| 13 |
D2: PATIENT-HELD INSTRUMENTS FOR RECORDING AMBULATORY CARE RESOURCE USE: EXPERIENCE IN PATIENTS WITH DIABETIC FOOT ULCERS
|
Constenia, D
|
|
1999
|
2 |
1 |
p. 17-
1 p.
|
artikel
|
| 14 |
D1: SELF-MONITORING OF BLOOD GLUCOSE IN DIABETES: IS IT WORTH IT?
|
Evans, JMM
|
|
1999
|
2 |
1 |
p. 17-
1 p.
|
artikel
|
| 15 |
GI1: COST-UTILITY ANALYSIS OF LAPAROSCOPIC VERSUS OPEN SURGERY FOR COLONIC DISEASE
|
Eypasch, E
|
|
1999
|
2 |
1 |
p. 8-9
2 p.
|
artikel
|
| 16 |
GI2: DIGEST INTERNATIONAL SURVEY: IMPACT OF UPPER GASTROINTESTINAL SYMPTOMS ON RESOURCE UTILIZATION AND QUALITY OF LIFE
|
Einarson, TR
|
|
1999
|
2 |
1 |
p. 9-
1 p.
|
artikel
|
| 17 |
GI3: THE EFFECT OF AN OPEN ACCESS ENDOSCOPY SERVICE ON PRESCRIBING COSTS OF ULCER-HEALING DRUGS
|
Davey, P
|
|
1999
|
2 |
1 |
p. 9-
1 p.
|
artikel
|
| 18 |
ID2: CIPROFLOXACIN IS MORE SUCCESSFUL AND COST-EFFECTIVE THAN TRIMETHOPRIM/SULFAMETHOXAZOLE IN THE ORAL AMBULATORY TREATMENT OF WOMEN WITH UNCOMPLICATED ACUTE PYELONEPHRITIS
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 12-
1 p.
|
artikel
|
| 19 |
ID1: IS TRIMETHOPRIM RESISTANCE AN OUTCOME OF COMMUNITY ANTIBIOTIC PRESCRIBING?
|
Steinke, D
|
|
1999
|
2 |
1 |
p. 11-
1 p.
|
artikel
|
| 20 |
IM1: ASSESSING THE VALUE OF EPOETIN-a VERSUS AUTOLOGOUS BLOOD DONATION IN ORTHOPEDIC SURGERY: A FEASIBILITY STUDY OF CONTINGENT VALUATION
|
Persson, U
|
|
1999
|
2 |
1 |
p. 18-19
2 p.
|
artikel
|
| 21 |
IM2: EPOETIN-α REDUCES POSTOPERATIVE LENGTH OF STAY IN PATIENTS UNDERGOING KNEE REPLACEMENT
|
Martens, L
|
|
1999
|
2 |
1 |
p. 19-
1 p.
|
artikel
|
| 22 |
Index
|
|
|
1999
|
2 |
1 |
p. 63-65
3 p.
|
artikel
|
| 23 |
Invited Speaker Biographical Summaries
|
|
|
1999
|
2 |
1 |
p. 51-58
8 p.
|
artikel
|
| 24 |
ISPOR Inaugural European Conference: An Overview
|
Rindress, Donna
|
|
1999
|
2 |
1 |
p. 3-4
2 p.
|
artikel
|
| 25 |
J3: HOW DO PATIENTS MAKE SATISFACTION JUDGMENTS? ANSWERS FROM STRUCTURAL EQUATION MODELING
|
Trudeau, E
|
|
1999
|
2 |
1 |
p. 6-
1 p.
|
artikel
|
| 26 |
J1: IDENTIFYING INITIAL DIAGNOSIS IN DATABASE RESEARCH
|
Lalla, DV
|
|
1999
|
2 |
1 |
p. 5-
1 p.
|
artikel
|
| 27 |
J2: REVIEW OF LEGISLATION RELATING TO PROMOTION OF MEDICINAL PRODUCTS IN THE EUROPEAN UNION—ARE HEALTH ECONOMICS DATA COVERED?
|
Duthie, T
|
|
1999
|
2 |
1 |
p. 5-6
2 p.
|
artikel
|
| 28 |
L1: COMPLIANCE WITH INHALED CORTICOSTEROIDS AND HOSPITALIZATION FOR ASTHMA
|
McMahon, AD
|
|
1999
|
2 |
1 |
p. 10-
1 p.
|
artikel
|
| 29 |
L4: CROSS-CULTURAL ADAPTATION OF THE PEDIATRIC ASTHMA CAREGIVER QUALITY OF LIFE QUESTIONNAIRE (PACQLQ) IN 19 COUNTRIES
|
Mear, I
|
|
1999
|
2 |
1 |
p. 11-
1 p.
|
artikel
|
| 30 |
L2: EFFECTIVENESS OF ORAL CIPROFLOXACIN IN THE TREATMENT OF EXACERBATIONS OF CHRONIC AIRWAY DISEASES
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 10-
1 p.
|
artikel
|
| 31 |
L3: QUALITY OF LIFE OF ASTHMA PATIENTS RELATIVE TO ASTHMA SEVERITY
|
Greiner, W
|
|
1999
|
2 |
1 |
p. 10-11
2 p.
|
artikel
|
| 32 |
MH3: ASSESSING THE SASKATCHEWAN DATABASE FOR OUTCOMES STUDIES OF DEPRESSION AND ITS TREATMENT
|
West, S
|
|
1999
|
2 |
1 |
p. 15-
1 p.
|
artikel
|
| 33 |
MH6: COST-UTILITY ANALYSIS OF RISPERIDONE IN CHRONIC SCHIZOPHRENIA
|
Iskedjian, M
|
|
1999
|
2 |
1 |
p. 16-17
2 p.
|
artikel
|
| 34 |
MH5: ECONOMIC IMPACT OF AGITATED AND AGGRESSIVE BEHAVIORS OF ELDERLY INDIVIDUALS DWELLING IN THE COMMUNITY IN FRANCE: 2. COST ANALYSIS
|
Cal, M-L
|
|
1999
|
2 |
1 |
p. 16-
1 p.
|
artikel
|
| 35 |
MH4: ECONOMIC IMPACT OF AGITATED AND AGGRESSIVE BEHAVIORS OF ELDERLY INDIVIDUALS DWELLING IN THE COMMUNITY IN FRANCE: I. EPIDEMIOLOGY
|
Cal, M-L
|
|
1999
|
2 |
1 |
p. 16-
1 p.
|
artikel
|
| 36 |
MH2: NEW BENZODIAZEPINE USE IS ASSOCIATED WITH AN AGE-RELATED RISK OF HOSPITALIZATION WITH FRACTURE AND OTHER TRAUMA: A POPULATION-BASED STUDY
|
Steinke, D
|
|
1999
|
2 |
1 |
p. 15-
1 p.
|
artikel
|
| 37 |
MH1: ROAD TRAFFIC ACCIDENTS ARE ASSOCIATED WITH BENZODIAZEPINE USE
|
Barbone, F
|
|
1999
|
2 |
1 |
p. 14-15
2 p.
|
artikel
|
| 38 |
Mission Statement and Objectives
|
|
|
1999
|
2 |
1 |
p. 2-
1 p.
|
artikel
|
| 39 |
ND1: AN 11-YEAR, CONTROLLED STUDY OF HEALTHCARE RESOURCE USE AND MORTALITY FOR PATIENTS WITH PARKINSON'S DISEASE
|
Donnan, P
|
|
1999
|
2 |
1 |
p. 7-
1 p.
|
artikel
|
| 40 |
ND4: CROSS-CULTURAL ADAPTATION OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE (MSQ) IN 14 LANGUAGES
|
Conway, K
|
|
1999
|
2 |
1 |
p. 8-
1 p.
|
artikel
|
| 41 |
ND3: ECONOMIC EVALUATION OF ACAMPROSATE IN MAINTAINING ABSTINENCE IN ALCOHOL-DEPENDENT PATIENTS
|
Annemans, L
|
|
1999
|
2 |
1 |
p. 8-
1 p.
|
artikel
|
| 42 |
PCA6: COST-EFFECTIVENESS OF GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREATIC CANCER
|
Trippoli, S
|
|
1999
|
2 |
1 |
p. 22-
1 p.
|
artikel
|
| 43 |
PCA7: COST ESTIMATION OF SEVERE NEUTROPENIA IN BELGIUM
|
Annemans, L
|
|
1999
|
2 |
1 |
p. 22-
1 p.
|
artikel
|
| 44 |
PCA8: COST-MINIMIZATION IN THE USE OF COLONY-STIMULATING FACTORS (CSFs) BASED ON CLINICAL PREDICTION MODELS (CPMs)
|
Lyman, GH
|
|
1999
|
2 |
1 |
p. 22-23
2 p.
|
artikel
|
| 45 |
PCA3: ECONOMIC CONSEQUENCES OF MONOCLONAL ANTIBODY 17-1A ADJUVANT THERAPY OF RESECTED DUKES' C COLORECTAL CARCINOMA IN GERMANY
|
Schädlich, PK
|
|
1999
|
2 |
1 |
p. 21-
1 p.
|
artikel
|
| 46 |
PCA4: OUTCOME OF MONOCLONAL ANTIBODY 17-IA ADJUVANT THERAPY OF RESECTED COLON CANCER DUKES' C IN GERMANY: A SUBGROUP ANALYSIS
|
Brecht, JG
|
|
1999
|
2 |
1 |
p. 21-
1 p.
|
artikel
|
| 47 |
PCA1: PHARMACOECONOMIC EFFICIENCY OF THE USE OF PROTEASE INHIBITORS FOR HOSPITAL INPATIENTS WITH AIDS
|
Rahmouni, S
|
|
1999
|
2 |
1 |
p. 20-
1 p.
|
artikel
|
| 48 |
PCA5: QUALITY OF LIFE IN HODGKIN'S DISEASE: RESULTS FROM THE EORTC AND GHSG TRIALS
|
Flechtner, H
|
|
1999
|
2 |
1 |
p. 21-22
2 p.
|
artikel
|
| 49 |
PCA9: QUALITY OF LIFE (QOL) OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA (IG-NHL) TREATED WITH FLUDARABINE (F) OR CYCLOPHOSPHAMIDE-VINCRISTINE-PREDNISONE (CVP)
|
Bérubé, S
|
|
1999
|
2 |
1 |
p. 23-
1 p.
|
artikel
|
| 50 |
PCA2: THE COST-EFFECTIVENESS OF ITRACONAZOLE SOLUTION IN THE TREATMENT OF ORAL CANDIDIASIS IN HIV/AIDS PATIENTS: AN INTERNATIONAL COMPARISON
|
McGann, ME
|
|
1999
|
2 |
1 |
p. 20-
1 p.
|
artikel
|
| 51 |
PCA10: THE RELATIONSHIP BETWEEN PROFILE-BASED QUALITY OF LIFE SCORES AND EUROQOL-5D SCORES IN BREAST CANCER SURGERY PATIENTS
|
Namjoshi, M
|
|
1999
|
2 |
1 |
p. 23-24
2 p.
|
artikel
|
| 52 |
PCIU4: CROSS-CULTURAL ADAPTATION OF THE PATIENT ASSESSMENT OF CONSTIPATION-SYMPTOM QUESTIONNAIRE (PAC-SYM)
|
Conway, K
|
|
1999
|
2 |
1 |
p. 29-
1 p.
|
artikel
|
| 53 |
PCIU5: RATE OF GASTROPROTECTIVE AGENT USE, DIAGNOSTIC TESTS, AND HOSPITALIZATIONS AMONG ELDERLY PATIENTS WHO STARTED ARTHROTEC, A FIXED COMBINATION OF MISOPROSTOL AND DICLOFENAC
|
Rahme, E
|
|
1999
|
2 |
1 |
p. 29-
1 p.
|
artikel
|
| 54 |
PCIU3: THE EFFECTS OF ULCER-HEALING DRUG COPRESCIPTION ON NSAID-INDUCED GASTROINTESTINAL EVENTS: A RECORD LINKAGE COHORT STUDY
|
Morant, SV
|
|
1999
|
2 |
1 |
p. 28-29
2 p.
|
artikel
|
| 55 |
PCV2: ADAPTING ECONOMIC ANALYSES FROM ONE COUNTRY TO ANOTHER: DO THE WOSCOPS UK FINDINGS HOLD IN BELGIUM?
|
Huybrechts, KF
|
|
1999
|
2 |
1 |
p. 24-
1 p.
|
artikel
|
| 56 |
PCV10: A HEALTH ECONOMIC EVALUATION OF HORMONE REPLACEMENT THERAPY IN BELGIUM
|
Arikian, SR
|
|
1999
|
2 |
1 |
p. 27-
1 p.
|
artikel
|
| 57 |
PCV9: COMPARISON OF THE EPIDEMIOLOGY AND COSTS ASSOCIATED WITH PRIMARY PREVENTION OF CORONARY HEART DISEASE IN FIVE EUROPEAN COUNTRIES
|
Munro, V
|
|
1999
|
2 |
1 |
p. 27-
1 p.
|
artikel
|
| 58 |
PCV1: COST-EFFECTIVENESS OF LIPID MODULATOR AGENTS
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 24-
1 p.
|
artikel
|
| 59 |
PCV7: CROSS-CULTURAL ADAPTATION OF THE SEATTLE ANGINA QUESTIONNAIRE (SAQ) IN I I COUNTRIES
|
Conway, K
|
|
1999
|
2 |
1 |
p. 26-
1 p.
|
artikel
|
| 60 |
PCV3: EFFICACY OF CARDIAC REHABILITATION THERAPY: A PROSPECTIVE MULTICENTER COHORT STUDY
|
Willich, SN
|
|
1999
|
2 |
1 |
p. 24-25
2 p.
|
artikel
|
| 61 |
PCV8: IMPACT OF CLINICAL SENSITIVITY ANALYSIS IN AN EVALUATION OF PRIMARY PREVENTION OF CORONARY HEART DISEASE IN GERMANY
|
Munro, V
|
|
1999
|
2 |
1 |
p. 26-27
2 p.
|
artikel
|
| 62 |
PCV6: MEASURING DISEASE-SPECIFIC SYMPTOM IMPACT: DEVELOPMENT OF THE ATRIAL FIBRILLATION IMPACT SCALE (AFIS)
|
Turner, R
|
|
1999
|
2 |
1 |
p. 25-26
2 p.
|
artikel
|
| 63 |
PCV5: POTENTIAL COST SAVINGS OF THE 4 FRENCH INFINITI CATHETER IN DIAGNOSTIC CORONARY ANGIOGRAPHY
|
Neighbors, D
|
|
1999
|
2 |
1 |
p. 25-
1 p.
|
artikel
|
| 64 |
PCV4: THE ECONOMIC IMPACT OF HYPERTENSION STUDY FROM THE PISTOIA PROJECT
|
Potenza, A
|
|
1999
|
2 |
1 |
p. 25-
1 p.
|
artikel
|
| 65 |
PD1: COMPLIANCE WITH AMERICAN DIABETIC ASSOCIATION (ADA) RECOMMENDATIONS IN A TYPE 2 DIABETIC POPULATION IN AN ACADEMIC FAMILY MEDICINE CENTER
|
Taylor, AT
|
|
1999
|
2 |
1 |
p. 30-
1 p.
|
artikel
|
| 66 |
PGIU2: EVALUATING CLINICAL OUTCOMES OF GERD TREATMENT OPTIONS USING DECISION ANALYSIS
|
McGhan, WF
|
|
1999
|
2 |
1 |
p. 28-
1 p.
|
artikel
|
| 67 |
PGIU1: WILLINGNESS TO PAY OF PATIENTS WITH PAINFUL-IRRITABLE BLADDER SYNDROME
|
Budhiarso, I
|
|
1999
|
2 |
1 |
p. 27-28
2 p.
|
artikel
|
| 68 |
PID1: COST-EFFECTIVENESS OF LEVOFLOXACIN VERSUS CLARITHROMYCIN IN PATIENTS EVALUABLE FOR CLINICAL EFFICACY IN THE TREATMENT OF ACUTE BACTERIAL SINUSITIS
|
Ranee, L
|
|
1999
|
2 |
1 |
p. 30-
1 p.
|
artikel
|
| 69 |
PID2: COST-MINIMIZATION ANALYSIS OF CEFAMANDOLE AND TOBRAMYCIN VERSUS STANDARD THERAPY IN THE TREATMENT OF PATIENTS WITH LOCAL APPENDICULAR PERITONITIS
|
Rozenson, O
|
|
1999
|
2 |
1 |
p. 30-31
2 p.
|
artikel
|
| 70 |
PIM1: COST-EFFECTIVENESS ANALYSIS OF A FIXED COMBINATION (DICLOFENAC 1 MISOPROSTOL) IN THE PREVENTION OF GASTROPATHY IN ARTHRITIS PATIENTS IN BELGIUM
|
Annemans, L
|
|
1999
|
2 |
1 |
p. 38-39
2 p.
|
artikel
|
| 71 |
PIM2: COST OF ILLNESS IN EARLY RHEUMATOID ARTHRITIS STRATIFIED FOR SOCIAL STATUS
|
Merkesdal, S
|
|
1999
|
2 |
1 |
p. 39-
1 p.
|
artikel
|
| 72 |
PIM3: QUALITY OF LIFE SCORES AS PREDICTORS OF FUTURE HEALTHCARE RESOURCE USE IN PATIENTS WITH ARTHRITIS
|
Kong, SX
|
|
1999
|
2 |
1 |
p. 39-40
2 p.
|
artikel
|
| 73 |
PMC6: ADVANCED SENSITIVITY ANALYSIS BY THE INTEGRATION OF POINT-SENSITIVITY AND RANGE-SENSITIVITY USING PROBABILITY DISTRIBUTIONS
|
Nuijten, MJC
|
|
1999
|
2 |
1 |
p. 42-
1 p.
|
artikel
|
| 74 |
PMC7: DIMINISHING THE COST OF HIGHLY PRESCRIBED DRUGS IN THE COMUNIDAD VALENCIANA (SPAIN)
|
Larruga, J
|
|
1999
|
2 |
1 |
p. 42-
1 p.
|
artikel
|
| 75 |
PMC4: LINKING HRQOLS TO LARGE NATIONAL DATA SETS: EUROQOL AND HUI INDICES
|
Rizzo, JA
|
|
1999
|
2 |
1 |
p. 41-
1 p.
|
artikel
|
| 76 |
PMC1: MEDICATION COMPLIANCE AND EXPENDITURE IMPACT ASSOCIATED WITH PHARMACIST'S COGNITIVE SERVICE INTERVENTIONS
|
Smith, D
|
|
1999
|
2 |
1 |
p. 40-
1 p.
|
artikel
|
| 77 |
PMC8: META-ANALYSIS OF ECONOMIC EVALUATIONS: A METHODOLOGICAL APPROACH AND CASE STUDY
|
Pang, F
|
|
1999
|
2 |
1 |
p. 42-43
2 p.
|
artikel
|
| 78 |
PMC2: RUNNING COST OF TREATING A PATIENT IN A GENERAL MEDICAL WARD IN SULTAN QABOOS UNIVERSITY HOSPITAL IN OMAN
|
Al-Zakwani, I
|
|
1999
|
2 |
1 |
p. 40-
1 p.
|
artikel
|
| 79 |
PMC3: SURVIVAL GAINS AND DEGREE OF THERAPEUTIC INNOVATION
|
Messori, A
|
|
1999
|
2 |
1 |
p. 40-41
2 p.
|
artikel
|
| 80 |
PMC5: USING A SURROGATE SAMPLE TO DERIVE PATIENT PREFERENCES FOR A COST-UTILITY ANALYSES IN A RANDOMIZED CLINICAL TRIAL
|
Lustig, S
|
|
1999
|
2 |
1 |
p. 41-42
2 p.
|
artikel
|
| 81 |
PMH1: ANNUAL DIRECT COSTS OF PSYCHOTROPIC MEDICATIONS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS IN INDIA
|
Chaturvedi, SK
|
|
1999
|
2 |
1 |
p. 31-
1 p.
|
artikel
|
| 82 |
PMH2: CLINICAL AND ECONOMIC CHARACTERIZATION OF FAMILY MEDICINE PATIENTS RECEIVING ANTIDEPRESSANT DRUGS
|
Taylor, AT
|
|
1999
|
2 |
1 |
p. 31-32
2 p.
|
artikel
|
| 83 |
PMH3: COST-EFFECTIVENESS OF FLUVOXAMINE IN THE TREATMENT OF RECURRENT DEPRESSION IN FRANCE
|
Nuijten, MJC
|
|
1999
|
2 |
1 |
p. 32-
1 p.
|
artikel
|
| 84 |
PMH5: COST OF ALZHEIMER'S DISEASE CARE IN THE UNITED KINGDOM
|
Thwaites, RMA
|
|
1999
|
2 |
1 |
p. 33-
1 p.
|
artikel
|
| 85 |
PMH7: CROSS-CULTURAL ADAPTATION OF THE INTERNATIONAL INDEX OF ERECTILE FUNCTION (IIEF) IN 31 COUNTRIES
|
Conway, K
|
|
1999
|
2 |
1 |
p. 33-34
2 p.
|
artikel
|
| 86 |
PMH6: DEVELOPMENT OF A NEW DISEASE-SPECIFIC QUALITY OF LIFE SCALE FOR USE IN SCHIZOPHRENIA
|
Wild, D
|
|
1999
|
2 |
1 |
p. 33-
1 p.
|
artikel
|
| 87 |
PMH8: EFFECT OF RISPERIDONE ON THE COST OF NURSING HOME CARE FOR RESIDENTS WITH BEHAVIORAL AND PSYCHOLOGICAL SIGNS AND SYMPTOMS
|
Caro, JJ
|
|
1999
|
2 |
1 |
p. 34-
1 p.
|
artikel
|
| 88 |
PMH4: THE BUDGET IMPACT PHARMACOTHERAPY SELECTION FOR MAJOR DEPRESSIVE DISORDER: A MULTINATIONAL STUDY
|
Casciano, JP
|
|
1999
|
2 |
1 |
p. 32-33
2 p.
|
artikel
|
| 89 |
PN3: A FOUNDATION STUDY FOR COSTEFFECTIVENESS ANALYSIS: THE DEFINITION OF ECONOMIC PARAMETERS AND CLINICAL ENDPOINTS IN PARKINSON'S DISEASE
|
Saal, G
|
|
1999
|
2 |
1 |
p. 35-
1 p.
|
artikel
|
| 90 |
PN1: A UK PRIMARY CARE DATABASE (UKPCD)-UK MEDIPLUS AS A READILY AVAILABLE RESEARCH TOOL FOR DETERMINING THE INCIDENCE AND PREVALENCE OF MULTIPLE SCLEROSIS, ITS TREATMENT, PRESCRIPTION COSTS, AND REFERRALS IN UK PRACTICE
|
Grigas, E
|
|
1999
|
2 |
1 |
p. 34-
1 p.
|
artikel
|
| 91 |
PN7: COST-EFFECTIVENESS OF PRAMIPEXOLE IN PARKINSON'S DISEASE IN THREE COUNTRIES
|
Hoerger, T
|
|
1999
|
2 |
1 |
p. 37-
1 p.
|
artikel
|
| 92 |
PN5: CROSS-CULTURAL ADAPTATION OF THE FUNCTIONAL ASSESSMENT OF MULTIPLE SCLEROSIS (FAMS) QUESTIONNAIRE IN NINE COUNTRIES
|
Conway, K
|
|
1999
|
2 |
1 |
p. 36-
1 p.
|
artikel
|
| 93 |
PN6: IMPACT OF A COST-SHARING DRUG INSURANCE PLAN ON DRUG UTILIZATION AMONG INDIVIDUALS RECEIVING SOCIAL ASSISTANCE
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 36-
1 p.
|
artikel
|
| 94 |
PN4: QUALITY OF LIFE AND FUNCTIONAL STATUS MEASURES IN ADVANCED PARKINSON'S PATIENTS TREATED WITH PRAMIPEXOLE, BROMOCRIPTINE, OR PLACEBO
|
Greer, M
|
|
1999
|
2 |
1 |
p. 35-36
2 p.
|
artikel
|
| 95 |
PN2: RESULTS OF DISEASE MANAGEMENT IN HEADACHE TREATMENT
|
Behrens, M
|
|
1999
|
2 |
1 |
p. 34-35
2 p.
|
artikel
|
| 96 |
PP1: CHARACTERISTICS OF CHRONIC AIRWAY DISEASE PATIENTS STARTED ON NEBULIZED IPRATROPIUM SOLUTION
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 37-
1 p.
|
artikel
|
| 97 |
PP4: ECONOMIC IMPACT OF SMOKING IN GERMANY
|
Ruff, L
|
|
1999
|
2 |
1 |
p. 38-
1 p.
|
artikel
|
| 98 |
PP3: INCREMENTAL COST OF DISEASE IN NOSOCOMIAL PNEUMONIA FROM A HOSPITAL'S PERSPECTIVE: A FEASIBILITY STUDY
|
Dietrich, ES
|
|
1999
|
2 |
1 |
p. 38-
1 p.
|
artikel
|
| 99 |
PP2: THE EFFECT OF AGE ON COST-EFFECTIVENESS IN THE TREATMENT OF MODERATE ASTHMA
|
Kielhorn, A
|
|
1999
|
2 |
1 |
p. 37-38
2 p.
|
artikel
|
| 100 |
W5: A NATURAL HISTORY OF ALZHEIMER'S DISEASE: PATH-DEPENDENT EVALUATION OF CLINICAL AND ECONOMIC OUTCOMES USING DECISION DATABASE METHODOLOGY
|
Arcelus, A
|
|
1999
|
2 |
1 |
p. 44-
1 p.
|
artikel
|
| 101 |
W11: DECISION ANALYSIS IN CANCER THERAPY, A NEW WAY FOR EVALUATION OUTCOMES WITH THE ANALYTIC HIERARCHY PROCESS (AHP)
|
Reibnitz, C
|
|
1999
|
2 |
1 |
p. 45-
1 p.
|
artikel
|
| 102 |
W14: DESIGNING AN INTERNATIONAL PIGGYBACK STUDY: PROVIDING THE FOUNDATION
|
Crawford, B
|
|
1999
|
2 |
1 |
p. 49-50
2 p.
|
artikel
|
| 103 |
W9: ECONOMIC EVALUATION OF REHABILITATION PROGRAMS: THE PERSPECTIVE OF SOCIAL OLD AGE INSURANCE FUNDS IN GERMANY
|
Seitz, R
|
|
1999
|
2 |
1 |
p. 49-
1 p.
|
artikel
|
| 104 |
Welccome
|
Epstein, Robert S.
|
|
1999
|
2 |
1 |
p. 1-
1 p.
|
artikel
|
| 105 |
W2: ESTIMATING DRUG EFFECTS: FROM CLINICAL TRIAL RESULTS TO ACTUAL PRACTICE
|
Caro, JJ
|
|
1999
|
2 |
1 |
p. 48-
1 p.
|
artikel
|
| 106 |
W3: ESTIMATING POPULATION BUDGET AND HEALTH IMPACTS OF NEW TREATMENTS
|
Mauskopf, JA
|
|
1999
|
2 |
1 |
p. 48-49
2 p.
|
artikel
|
| 107 |
W7: HANDLING SURVIVAL DATA IN COST-EFFECTIVENESS ANALYSIS
|
Trippoli, S
|
|
1999
|
2 |
1 |
p. 49-
1 p.
|
artikel
|
| 108 |
W18: HEALTH STATUS AND QUALITY OF LIFE MEASURES IN INTERNATIONAL CLINICAL RESEARCH
|
Marquis, P
|
|
1999
|
2 |
1 |
p. 48-
1 p.
|
artikel
|
| 109 |
WI7: STANDARDIZATION IN THE PUBLIC HEALTH SYSTEM OF RUSSIA: THE FIRST EXPERIENCE
|
Vorobyev, PA
|
|
1999
|
2 |
1 |
p. 46-47
2 p.
|
artikel
|
| 110 |
Wl2: DEVELOPING INTERACTIVE COMPUTER SOFTWARE FOR EVALUATING THE ECONOMIC AND CLINICAL OUTCOMES OF VARIOUS TREATMENT STRATEGIES
|
McGhan, WF
|
|
1999
|
2 |
1 |
p. 45-
1 p.
|
artikel
|
| 111 |
Wl: THE DARTS DIABETES DATABASE: HOW CAN QUALITY OF LIFE MEASUREMENTS FOR OUTCOMES RESEARCH BE INCORPORATED?
|
Evans, JMM
|
|
1999
|
2 |
1 |
p. 47-
1 p.
|
artikel
|
| 112 |
W4: MONTE CARLO SIMULATION IN HEALTHCARE MODELS
|
Richter, A
|
|
1999
|
2 |
1 |
p. 44-
1 p.
|
artikel
|
| 113 |
W10: PRO AND CON: USE OF DATA FROM FOREIGN PHARMACOECONOMIC INVESTIGATIONS IN RUSSIA
|
Stratchounski, L
|
|
1999
|
2 |
1 |
p. 46-
1 p.
|
artikel
|
| 114 |
W15: SELF-REPORTED RESOURCE UTILIZATION DATA IN PHARMACOECONOMIC TRIALS: THEIR USE AND IMPACT ON STUDY VALIDITY
|
Crawford, B
|
|
1999
|
2 |
1 |
p. 50-
1 p.
|
artikel
|
| 115 |
W20: STANDARD PROCEDURES FOR ECONOMIC EVALUATION: USING A COMPUTER PROGRAM FOR REPORTING ECONOMIC EVALUATIONS RESULTS (REER)
|
Rovira, J
|
|
1999
|
2 |
1 |
p. 47-
1 p.
|
artikel
|
| 116 |
W6: THE APPROPRIATENESS OF COMMON MEDICAL DATA SOURCES: RANDOMIZED TRIALS, META-ANALYSES, EPIDEMIOLOGICAL AND OBSERVATIONAL STUDIES FOR PHARMACOECONOMIC ANALYSES
|
Hasford, J
|
|
1999
|
2 |
1 |
p. 45-
1 p.
|
artikel
|
| 117 |
W19: THE BOOTSTRAP STATISTICAL METHOD FOR THE PHARMACOECONOMIC COST ANALYSIS OF SKEWED DATA
|
LeLorier, J
|
|
1999
|
2 |
1 |
p. 50-
1 p.
|
artikel
|
| 118 |
W8: THE DEVELOPMENT AND IMPLEMENTATION OF FORMULARY SUBMISSION GUIDELINES FOR MANAGED CARE IN THE UNITED STATES
|
Langley, P
|
|
1999
|
2 |
1 |
p. 45-46
2 p.
|
artikel
|
| 119 |
W13: THE USE OF PROXIES TO COLLECT HEALTHCARE RESOURCES AND QUALITY OF LIFE DATA
|
Crawford, B
|
|
1999
|
2 |
1 |
p. 47-48
2 p.
|
artikel
|
Tijdschrift beschrijving